Page last updated: 2024-09-05

5-fluorotryptamine monohydrochloride and ipratropium bromide anhydrous

5-fluorotryptamine monohydrochloride has been researched along with ipratropium bromide anhydrous in 1 studies

Compound Research Comparison

Studies
(5-fluorotryptamine monohydrochloride)
Trials
(5-fluorotryptamine monohydrochloride)
Recent Studies (post-2010)
(5-fluorotryptamine monohydrochloride)
Studies
(ipratropium bromide anhydrous)
Trials
(ipratropium bromide anhydrous)
Recent Studies (post-2010) (ipratropium bromide anhydrous)
6021717

Protein Interaction Comparison

ProteinTaxonomy5-fluorotryptamine monohydrochloride (IC50)ipratropium bromide anhydrous (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.0021
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0028
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0019

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1

Other Studies

1 other study(ies) available for 5-fluorotryptamine monohydrochloride and ipratropium bromide anhydrous

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016